Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.858 USD | -0.28% | -16.86% | -33.62% |
Apr. 25 | OptiNose, Inc. Provides Revenue Guidance for the First Quarter of 2024 | CI |
Apr. 25 | Transcript : OptiNose, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.62% | 97.26M | |
+25.78% | 661B | |
+26.74% | 566B | |
-6.73% | 352B | |
+19.46% | 332B | |
+3.35% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.15% | 145B |
- Stock Market
- Equities
- OPTN Stock
- News OptiNose, Inc.
- OptiNose Says US FDA Approves Xhance to Treat Chronic Rhinosinusitis